Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2025-03-14 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 80% confidence The document is a brief announcement issued by the company to notify shareholders and the market of an upcoming board meeting date, where the Board will consider approving annual results and recommending a final dividend. It does not contain any actual financial results, filings, or presentations; it is not an AGM notice, not a results release, nor a management change announcement. It also does not attach or publish the report itself, but simply notifies the date of a Board meeting. This kind of miscellaneous regulatory announcement falls under the fallback category of Regulatory Filings (RNS).
2025-03-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Share Issue/Capital Change Classification · 85% confidence The document is a Hong Kong Exchange Listing Rule monthly return (Form FF301) detailing movements in authorised/registered share capital, issued shares, treasury shares, share option schemes, warrants, convertibles, and other capital arrangements for the month ended 28 February 2025. It is not an earnings release, management discussion, or voting result but a regulatory submission on share capital changes. This matches the “Share Issue/Capital Change” category (SHA).
2025-03-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Regulatory Filings Classification · 82% confidence The document is a mandatory monthly return (Form FF301) filed by a Hong Kong–listed issuer to HKEX detailing share capital movements, issuance, treasury shares, and share option activities under Listing Rule Chapter 19B. It is not an investor presentation, earnings release, or annual/interim report, nor a discrete share issue announcement or proxy statement. This routine regulatory compliance filing does not neatly map to financing (CAP) or share issue (SHA) categories alone and thus falls under the general ‘Regulatory Filings’ fallback category (RNS).
2025-02-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong Listing Rules detailing changes in issued shares, treasury shares, and a share repurchase report for Transcenta Holding Limited, including share buyback quantities, prices, and confirmations. This type of filing is a report of the company buying back or selling its own shares. It does not announce an upcoming report, nor is it a full annual/interim report, financing update or management change. This matches the “Transaction in Own Shares” category.
2025-01-14 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong Listing Rules, reporting changes in issued shares and treasury shares, specifically detailing a share repurchase and treasury share transactions. This aligns with the category for company share buybacks/treasury share transactions. Hence, it is classified as Transaction in Own Shares (POS).
2025-01-10 English
Change of Address of Principal Place of Business in Hong Kong
Regulatory Filings Classification · 90% confidence The document is a short announcement (1,389 characters) notifying the market of a change in the company’s principal place of business address in Hong Kong, with no financial data, shareholder votes, or detailed report attached. It does not fit into other specific filing categories (e.g., board changes, dividends, financing updates). This is a general regulatory announcement of an operational change, so it falls into the fallback category of Regulatory Filings (RNS).
2025-01-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.